1. Home
  2. TG vs IPHA Comparison

TG vs IPHA Comparison

Compare TG & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$8.06

Market Cap

273.5M

Sector

Industrials

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.44

Market Cap

160.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TG
IPHA
Founded
1988
1999
Country
United States
France
Employees
N/A
174
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.5M
160.7M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
TG
IPHA
Price
$8.06
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
128.0K
13.6K
Earning Date
06-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
151.06
N/A
EPS
0.96
N/A
Revenue
$800,821,000.00
N/A
Revenue This Year
N/A
$28.31
Revenue Next Year
N/A
N/A
P/E Ratio
$8.13
N/A
Revenue Growth
8.29
N/A
52 Week Low
$6.25
$1.40
52 Week High
$9.66
$2.63

Technical Indicators

Market Signals
Indicator
TG
IPHA
Relative Strength Index (RSI) 42.37 30.33
Support Level $7.34 N/A
Resistance Level $9.14 $1.88
Average True Range (ATR) 0.39 0.08
MACD -0.16 -0.02
Stochastic Oscillator 25.63 0.43

Price Performance

Historical Comparison
TG
IPHA

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: